
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’s third-quarter 2025 earnings surpassed analyst estimates.
West Pharmaceutical reported adjusted earnings of $1.96 per share, beating the consensus of $1.68.